Lung Cancer News and Research

Latest Lung Cancer News and Research

Sanofi-aventis, Regeneron announce results of VEGF Trap Phase III trial in second-line NSCLC

Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced results from the Phase III VITAL trial evaluating the investigational agent aflibercept (VEGF Trap) for the second-line treatment of non-small cell lung cancer (NSCLC).

11 Mar 2011

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

10 Mar 2011

Scientists identify chemical compound that may lead to cancer-fighting drugs

Researchers at UT Southwestern Medical Center have identified a chemical compound that may eventually lead to a drug that fights cancers that are dependent on a particular anti-viral enzyme for growth.

10 Mar 2011

Experimental drug effectively shuts off MCL1 gene and induces apoptosis

Predictive Biomarker Sciences (PBS-Bio) has uncovered how the experimental drug UNBS1450, produced by Unibioscreen, kills cancer cells.

10 Mar 2011

Survey: Most HIV-positive patients die of cancer

Most HIV-positive patients die of cancer. In the latest issue of Deutsches Ärzteblatt International, Manfred Hensel's research group presents epidemiological data.

9 Mar 2011

New discovery can provide insight into lung cancer

A discovery at University of Colorado Cancer Center shows testing lung cancer on a molecular level can produce new insights into this deadly disease.

8 Mar 2011

Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product

ZIOPHARM Oncology, Inc., an oncology small molecule and synthetic biology drug development company, and Solasia Pharma K.K., a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today that they have entered into a license and collaboration agreement to develop and commercialize ZIOPHARM's darinaparsin product and related organic arsenic molecules in specified Pan-Asian/Pacific territories.

7 Mar 2011

New research: Lung cancer rates have doubled for women over 60 since mid 1970s

Lung cancer rates have doubled for women over 60 since the mid 1970s according to new Cancer Research UK figures released today ahead of No Smoking Day this Wednesday.

7 Mar 2011

Scientists develop unique device to measure short-lived radioactive thoron

"Many people are now saying: 'Is it really that easy? Then why didn't anyone think of it a long time ago?' But you have to have the right idea at the right time," says Annette Röttger, physicist at the Physikalisch-Technische Bundesanstalt, in a pleased way. Annette Röttger and her scientific team managed to do something that was previously thought to be impossible: they developed a primary standard for the measurement of short-lived radioactive thoron.

7 Mar 2011

IASLC to grant awards for five different advocacy groups on 14th World Conference on Lung Cancer

Lung and thoracic cancer advocacy organizations are invited to apply for travel awards to send their representatives to the 14th World Conference on Lung Cancer, to be held July 3-7, 2011 in Amsterdam.

5 Mar 2011

How cancer impacts patients and their partners

Katarina Sjövall has studied partners of individuals with colorectal cancer, lung cancer, breast cancer or prostate cancer. The study shows that the number of diagnosed diseases among partners increased by 25 per cent after the cancer diagnosis.

4 Mar 2011

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

The American Thoracic Society has released a new report detailing recent global changes in the management of human immunodeficiency virus-associated pulmonary disease.

4 Mar 2011

First artificial bronchus graft in a lung cancer patient successful

In a medical breakthrough French surgeons have grafted an artificial airway to save a lung afflicted by bronchial cancer in a 78-year-old man. The bronchi are the main tubes or airways used for taking air from the trachea to the two sides of the lung.

3 Mar 2011

Scientist receives $4 million Australia fellowship to continue cancer origin research

Walter and Eliza Hall Institute cancer researcher Professor Jane Visvader has received a $4 million fellowship from the Australian Government to continue her work into the origin of breast, ovarian and lung cancers.

3 Mar 2011

VICC introduces nation's first personalized cancer decision support tool

Vanderbilt-Ingram Cancer Center has launched the nation's first personalized cancer decision support tool, "My Cancer Genome," to help physicians and researchers track the latest developments in personalized cancer medicine and connect with clinical research trials for their patients.

3 Mar 2011

Genetics and cancer research

The 20th century was dominated by breakthroughs in physics and chemistry, but the 21st century will belong to genetics and biotechnology. Cancer research is just one area among many that is being transformed by the sequencing of the human genome. This was one of the topics discussed in our recent panel with leading cancer researchers, part of our Breakthroughs: Cancer series.

3 Mar 2011

Protein serum amyloid A could be a potential diagnostic biomarker for lung cancer

Scientists are reporting discovery of a protein in the blood of lung cancer patients that could be used in a test for the disease - difficult to diagnose in its earliest and most treatable stages - and to develop drugs that stop lung cancer from spreading. Their study appears in ACS's Journal of Proteome Research.

3 Mar 2011

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

Everyone knows someone that has been touched by cancer. Over one and a half million Americans will be diagnosed with some form of cancer in 2011, and more than 560,000 will die from the disease, accounting for 1 out of every 5 deaths.

2 Mar 2011

Level 3, ALA sign agreement to provide DIA, voice services to improve lung health awareness

Level 3 Communications, Inc. today announced that it has signed an agreement with the American Lung Association of the Midland States, a non-profit healthcare organization serving Kentucky, Michigan, Ohio and Tennessee, to provide dedicated Internet access and voice services in support of its mission to improve lung health awareness.

2 Mar 2011

NCI sponsors multi-center phase 2 study of entinostat-anastrozole combination in triple negative breast cancer

Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced the National Cancer Institute (NCI) will sponsor a multi-center phase 2 study of Syndax's lead product entinostat, a novel inhibitor of histone deacetylases (HDAC), and anastrozole, an aromatase inhibitor, in postmenopausal women with operable triple negative breast cancer to evaluate biomarkers and surrogates for response.

2 Mar 2011

Lung Cancer News and Research

Latest Lung Cancer News and Research

Sanofi-aventis, Regeneron announce results of VEGF Trap Phase III trial in second-line NSCLC

Idera reports $6.0 million net loss for fourth quarter 2010

Scientists identify chemical compound that may lead to cancer-fighting drugs

Experimental drug effectively shuts off MCL1 gene and induces apoptosis

Survey: Most HIV-positive patients die of cancer

New discovery can provide insight into lung cancer

Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product

New research: Lung cancer rates have doubled for women over 60 since mid 1970s

Scientists develop unique device to measure short-lived radioactive thoron

IASLC to grant awards for five different advocacy groups on 14th World Conference on Lung Cancer

How cancer impacts patients and their partners

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

First artificial bronchus graft in a lung cancer patient successful

Scientist receives $4 million Australia fellowship to continue cancer origin research

VICC introduces nation's first personalized cancer decision support tool

Genetics and cancer research

Protein serum amyloid A could be a potential diagnostic biomarker for lung cancer

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

Level 3, ALA sign agreement to provide DIA, voice services to improve lung health awareness

NCI sponsors multi-center phase 2 study of entinostat-anastrozole combination in triple negative breast cancer

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in